XML 43 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition (Tables)
6 Months Ended
Jun. 30, 2021
Summary of Disaggregation of Revenues

The following table disaggregates our product revenue, net by product and geographic region and disaggregates our other revenues by geographic region (in thousands):

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

June 30, 2021

 

 

June 30, 2020

 

 

 

U.S.

 

 

Non U.S.

 

 

Total

 

 

U.S.

 

 

Non U.S.

 

 

Total

 

Product revenue, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HEPLISAV-B

 

$

13,688

 

 

$

-

 

 

$

13,688

 

 

$

2,405

 

 

$

-

 

 

$

2,405

 

CpG 1018

 

 

-

 

 

 

38,989

 

 

 

38,989

 

 

 

-

 

 

 

-

 

 

 

-

 

Total product revenue, net

 

$

13,688

 

 

$

38,989

 

 

$

52,677

 

 

$

2,405

 

 

$

-

 

 

$

2,405

 

Other revenue

 

 

-

 

 

 

90

 

 

 

90

 

 

 

-

 

 

 

263

 

 

 

263

 

Total revenues

 

$

13,688

 

 

$

39,079

 

 

$

52,767

 

 

$

2,405

 

 

$

263

 

 

$

2,668

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

Six Months Ended

 

 

 

June 30, 2021

 

 

June 30, 2020

 

 

 

U.S.

 

 

Non U.S.

 

 

Total

 

 

U.S.

 

 

Non U.S.

 

 

Total

 

Product revenue, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HEPLISAV-B

 

$

21,991

 

 

$

-

 

 

$

21,991

 

 

$

12,919

 

 

$

-

 

 

$

12,919

 

CpG 1018

 

 

-

 

 

 

113,571

 

 

 

113,571

 

 

 

-

 

 

 

-

 

 

 

-

 

Total product revenue, net

 

$

21,991

 

 

$

113,571

 

 

$

135,562

 

 

$

12,919

 

 

$

-

 

 

$

12,919

 

Other revenue

 

 

260

 

 

 

280

 

 

 

540

 

 

 

-

 

 

 

668

 

 

 

668

 

Total revenues

 

$

22,251

 

 

$

113,851

 

 

$

136,102

 

 

$

12,919

 

 

$

668

 

 

$

13,587

 

Summary of Deferred Revenue The following table summarizes balances and activities in our deferred revenue accounts for the six months ended June 30, 2021 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at

Beginning

of Period

 

 

Additions (1)

 

 

Subtractions (2)

 

 

Revenue recognized in the current period included in deferred revenue balance at the beginning of the period

 

 

Balance

at End of

Period

 

Six months ended June 30, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue

 

$

38,212

 

 

$

140,596

 

 

$

(12,199

)

 

$

(37,052

)

 

$

129,557

 

Long-term deferred revenue

 

 

-

 

 

 

109,532

 

 

 

(2,582

)

 

 

-

 

 

 

106,950

 

 

(1)

Additions are primarily payments received or invoices issued before we satisfy our performance obligations.

(2)

Subtractions are primarily revenues recognized in the period included in deferred revenue during the period.  

HEPLISAV-B  
Schedule of Revenues from Major Customers

The following table summarizes HEPLISAV-B product revenue from each of our three largest Customers (as a percentage of total HEPLISAV-B product revenue):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Largest Customer

 

 

28

%

 

 

40

%

 

 

28

%

 

 

25

%

Second largest Customer

 

 

21

%

 

 

26

%

 

 

23

%

 

 

24

%

Third largest Customer

 

 

16

%

 

 

17

%

 

 

17

%

 

 

17

%

Summary of Product Revenue Allowance and Reserve Categories

The following table summarizes balances and activities in HEPLISAV-B product revenue allowance and reserve categories for the six months ended June 30, 2021 (in thousands):

 

 

 

Balance at

Beginning

of Period

 

 

Provisions

related to

current

period sales

 

 

Credit or

payments

made during

the period

 

 

Balance

at End of

Period

 

Six months ended June 30, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable reserves(1)

 

$

2,836

 

 

$

7,345

 

 

$

(6,820

)

 

$

3,361

 

Revenue reserve accruals(2)

 

$

6,040

 

 

$

4,117

 

 

$

(3,104

)

 

$

7,053

 

 

(1)

Reserves are for chargebacks, discounts and other fees.

(2)

Accruals are for returns, rebates and other fees.

CpG 1018  
Schedule of Revenues from Major Customers

The following table summarizes CpG 1018 product revenue from each of our two largest collaboration partners (as a percentage of total CpG 1018 product revenue):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Largest collaboration partner

 

 

63

%

 

 

0

%

 

 

79

%

 

 

0

%

Second largest collaboration partner

 

 

27

%

 

 

0

%

 

 

15

%

 

 

0

%